rs309369
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_152618.3(BBS12):c.378G>T(p.Glu126Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00322 in 1,613,782 control chromosomes in the GnomAD database, including 151 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_152618.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS12 | NM_152618.3 | c.378G>T | p.Glu126Asp | missense_variant | 2/2 | ENST00000314218.8 | NP_689831.2 | |
BBS12 | NM_001178007.2 | c.378G>T | p.Glu126Asp | missense_variant | 3/3 | NP_001171478.1 | ||
BBS12 | XM_011531680.3 | c.378G>T | p.Glu126Asp | missense_variant | 2/2 | XP_011529982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BBS12 | ENST00000314218.8 | c.378G>T | p.Glu126Asp | missense_variant | 2/2 | 1 | NM_152618.3 | ENSP00000319062.3 | ||
BBS12 | ENST00000542236.5 | c.378G>T | p.Glu126Asp | missense_variant | 3/3 | 2 | ENSP00000438273.1 | |||
BBS12 | ENST00000433287.1 | c.378G>T | p.Glu126Asp | missense_variant | 3/3 | 2 | ENSP00000398912.1 |
Frequencies
GnomAD3 genomes AF: 0.0176 AC: 2673AN: 152146Hom.: 70 Cov.: 33
GnomAD3 exomes AF: 0.00430 AC: 1074AN: 249912Hom.: 28 AF XY: 0.00307 AC XY: 415AN XY: 135202
GnomAD4 exome AF: 0.00173 AC: 2529AN: 1461518Hom.: 81 Cov.: 31 AF XY: 0.00148 AC XY: 1075AN XY: 727056
GnomAD4 genome AF: 0.0176 AC: 2675AN: 152264Hom.: 70 Cov.: 33 AF XY: 0.0169 AC XY: 1256AN XY: 74452
ClinVar
Submissions by phenotype
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 13, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 10, 2021 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | This variant is associated with the following publications: (PMID: 20498079) - |
Bardet-Biedl syndrome 12 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Bardet-Biedl syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at